Animal drugs, feeds, and related products: Lasalocid,

[Federal Register: November 21, 2006 (Volume 71, Number 224)]

[Rules and Regulations]

[Page 67299-67300]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr21no06-4]

[[Page 67299]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558

New Animal Drugs for Use in Animal Feeds; Lasalocid

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for the use of lasalocid Type A medicated articles containing 20 percent lasalocid activity per pound to make free-choice Type C medicated feeds used for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers).

DATES: This rule is effective November 21, 2006.

FOR FURTHER INFORMATION CONTACT: Eric S. Dubbin, Center for Veterinary Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855; tel: 301-827-0232; e-mail: eric.dubbin@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Alpharma Inc., One Executive Dr., Fort Lee, NJ 07024, filed a supplement to NADA 96-298 for use of BOVATEC 91 (lasalocid) Type A medicated article (20 percent lasalocid activity per pound) to make free-choice Type C medicated feeds used for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). The supplemental NADA is approved as of October 20, 2006, and the regulations are amended in 21 CFR 558.311 to reflect the approval. The basis of approval is discussed in the freedom of information summary.

In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.

The agency has determined under 21 CFR 25.33(a)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.

This rule does not meet the definition of ``rule'' in 5 U.S.C. 804(3)(A) because it is a rule of ``particular applicability.'' Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

List of Subject in 21 CFR Part 558

Animal drugs, Animal feeds.

0 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:

PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

0 1. The authority citation for 21 CFR part 558 continues to read as follows:

Authority: 21 U.S.C. 360b, 371.

0 2. In Sec. 558.311, revise paragraphs (e)(2)(i), (e)(2)(ii), (e)(3)(i), (e)(3)(ii), and (e)(4)(i) to read as follows:

Sec. 558.311 Lasalocid.

* * * * *

(e) * * *

(2) * * *

(i) Specification.

International Ingredient

Percent feed No.

Defluorinated phosphate (20.5% Ca, 18.5% P)... 35.9 6-01-080 Sodium chloride (salt)........................ 20.0 6-04-152 Calcium carbonate (38% Ca).................... 18.0 6-01-069 Cottonseed meal............................... 10.0 5-01-621 Potassium chloride............................ 3.0 6-03-755 Selenium premix (0.02 percent Se)\1\.......... 3.0 ............. Dried cane molasses (46% sugars).............. 2.5 4-04-695 Magnesium sulfate............................. 1.7 6-02-758 Vitamin premix\1\............................. 1.4 ............. Magnesium oxide (58% Mg)...................... 1.2 6-02-756 Potassium sulfate............................. 1.2 6-06-098 Trace mineral premix\1\....................... 1.04 ............. Lasalocid Type A medicated article (68 g/

1.06 ............. lb)\2\.......................................

\1\ Content of the vitamin and trace mineral premixes may be varied; however, they should be comparable to those used by the firm for other free-choice feeds. Formulation modifications require FDA approval prior to marketing. Selenium must comply with 21 CFR 573.920. Ethylenediamine dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides Sec. 651.100 (CPG 7125.18). \2\ To provide 1,440 g lasalocid per ton, use 21.2 lbs (1.06%) of a lasalocid Type A medicated article containing 68 g/lb. If using a lasalocid Type A medicated article containing 90.7 g/lb, use 15.88 lbs per ton (0.794%), adding molasses.

(ii) Amount. 1,440 grams per ton. * * * * *

(3) * * *

(i) Specification.

International Ingredient

Percent feed No.

Cane molasses................................. 55.167 4-13-241 Condensed molasses fermentation solubles...... 24.0 ............. 50% Urea Solution (23% N)..................... 12.0 ............. Ammonium polyphosphate solution............... 1.0

6-08-42 Phosphoric acid (54%)......................... 3.0

6-03-707 Xanthan gum................................... 0.05 8-15-818

[[Page 67300]]

Water......................................... 4.0 ............. Trace mineral premix\1\....................... 0.5 ............. Vitamin premix\1\............................. 0.2 ............. Lasalocid Type A medicated article (90.7 g/

0.083 ............. lb)\2\.......................................

\1\ Content of the vitamin and trace mineral premixes may be varied; however, they should be comparable to those used by the firm for other free-choice feeds. Formulation modifications require FDA approval prior to marketing. Selenium must comply with 21 CFR 573.920. Ethylenediamine dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides Sec. 651.100 (CPG 7125.18). \2\ To provide 150 gm lasalocid per ton, use 1.652 lb (0.083%) of a lasalocid liquid Type A medicated article containing 90.7 g/lb. If using a dry lasalocid Type A medicated article containing 68 g/lb, use, use 2.206 lbs per ton (0.111%), replacing molasses. If using a dry lasalocid Type A medicated article containing 90.7 g/lb, use 1.652 lbs per ton (0.083%), adding molasses.

(ii) Amount. 150 grams per ton. * * * * *

(4) * * *

(i) Specification.

International Ingredient

Percent feed No.

Monocalcium phosphate (21% P)................. 57.70 6-01-082 Salt.......................................... 17.55 6-04-152 Distillers dried grains w/ solubles........... 5.40 5-28-236 Dried cane molasses (46% Sugars).............. 5.20 4-04-695 Potassium chloride............................ 4.90 6-03-755 Trace mineral/vitamin premix\1\............... 3.35 ............. Calcium carbonate (38% Ca).................... 2.95 6-01-069 Mineral oil................................... 1.05 8-03-123 Magnesium oxide (58% Mg)...................... 1.00 6-02-756 Iron oxide (52% Fe)........................... 0.10 6-02-431 Lasalocid Type A medicated article (68 g/

0.80 ............. lb)\2\.......................................

\1\ Content of the vitamin and trace mineral premixes may be varied; however, they should be comparable to those used by the firm for other free-choice feeds. Formulation modifications require FDA approval prior to marketing. Selenium must comply with 21 CFR 573.920. Ethylenediamine dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides Sec. 651.100 (CPG 7125.18). \2\ To provide 1,088 g lasalocid per ton, use 16 lbs (0.80%) of a lasalocid Type A medicated article containing 68 g/lb. If using a lasalocid Type A medicated article containing 90.7 g/lb, use 12 lbs per ton (0.6%), adding molasses.

* * * * *

Dated: November 7, 2006. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

[FR Doc. E6-19614 Filed 11-20-06; 8:45 am]

BILLING CODE 4160-01-S

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT